Swissmedic Information Sheet on Combination Studies: Modifications
The new article clarifies the approach to be followed when introducing modifications to combination studies already approved by Swissmedic.
The new article clarifies the approach to be followed when introducing modifications to combination studies already approved by Swissmedic.
The new article outlines the reporting requirements to be followed by the parties responsible for clinical investigations conducted in Switzerland.
The new article provides comprehensive guidance on the reporting form to be used in the context of performance studies involving in vitro diagnostic medical devices.
The new article describes in detail specific aspects related to the reporting requirements associated with performance studies involving in vitro diagnostic medical devices.
The new article provides an in-depth overview of the reporting requirements associated with performance studies involving in vitro diagnostic medical devices.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report